A carregar...
Adjuvant and Neoadjuvant Systemic Therapy for Pancreas Adenocarcinoma
The last two decades of research in the adjuvant setting of pancreas adenocarcinoma have established the value of adjuvant systemic therapy as being able to delay recurrence and increase overall survival. International standards of care in the adjuvant setting include either 6 months of gemcitabine...
Na minha lista:
| Publicado no: | Semin Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991774/ https://ncbi.nlm.nih.gov/pubmed/25726058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2014.12.012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|